Start Time: 08:30 January 1, 0000 9:27 AM ET
SOPHiA GENETICS SA (NASDAQ:SOPH)
Q3 2022 Earnings Conference Call
November 08, 2022, 08:30 AM ET
Company Participants
Jurgi Camblong - Founder and CEO
Ross Muken - CFO
Philippe Menu - Chief Medical Officer
Jennifer Pottage - Head, IR
Conference Call Participants
Julia Qin - JPMorgan
Kyle Boucher - Cowen
Vidyun Bais - BTIG
Operator
Good morning, everyone, and welcome to the SOPHiA GENETICS Third Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions]. After today's presentation, there will be an opportunity to ask questions. [Operator Instructions]. Please also note today's event is being recorded.
At this time, I'd like to turn the floor over to Jennifer Pottage, Head of Investor Relations. Ma'am, please go ahead.
Jennifer Pottage
Good morning and thank you for joining us on SOPHiA GENETICS Q3 fiscal 2022 earnings call. My name is Jennifer Pottage, and I'm the Head of Investor Relations at SOPHiA. Joining me today are Dr. Jurgi Camblong, our Co-Founder and Chief Executive Officer; Dr. Philippe Menu, our Chief Medical Officer; and Ross Muken, our Chief Financial Officer.
Before we get started, I would like to remind you that management will be making statements during this call that are forward-looking within the scope of U.S. federal securities laws. These statements are based on management's current views and assumptions which are subject to material risks and uncertainties that could cause actual results or events to differ materially from those projected. Additional information regarding these risks and uncertainties are included in the section entitled cautionary statements regarding forward-looking statements and Exhibit 99.2 of the report on Form 6-K filed today with the SEC.
Except as required by law, SOPHiA GENETICS disclaims any intention or obligation to update or revise any forward-looking statements whether because of new information, future events or otherwise. This conference call contains time-sensitive information and is accurate only as of its broadcast, November 8, 2022. Please note, both the replay of this call and a copy of the earnings release will be available on our Web site in the Investor Relations section.
And now, I'll turn the call over to Jurgi. Jurgi?
Jurgi Camblong
Thank you, Jen, and hello, everyone. We appreciate you joining us on our call this morning. I'm pleased to share that our results for the third quarter remains strong with accelerating organic growth and improved operating leverage, demonstrating our commitment to sustainable growth despite a negative impact from foreign exchange rates on our reported results.